Question-and-Answer Session
Operator
(Operator Instruction) And our first question today comes from Glenn Navarro with RBC Capital Markets.
Glenn Novarro – RBC Capital Markets
Good afternoon guys, two questions. One and I asked this question on an earlier conference call. I just wanted to clarify your comments about the overall market. Are you saying that the end markets in which you play are not slowing. In other words, the economy and perhaps the elective nature of spinal procedure is not slowing because of the economy or are you saying that Alphatec is gaining more each year and because you are smaller player within the market your business is not being impacted by the broader market dynamics? That is the question one, and then two, I am wondering if you can give us any more info on OsseoFix, perhaps, similar in the ballpark of how many patients you think you may have to enroll. Is there a follow up time and maybe a range of when you can actually send in an FDA filing?
Dirk Kuyper
Okay. Hi Glenn, this is Dirk, in relation to your first question. We are obviously in constant contact with a number of our surgeons and we have not seen a substantial change in their practices. In fact, some of them seemed to be as busy as ever but you know that does not mean that sort of in the general economy, there is no slow down. We would not know about that as early as this point but we are obviously grabbing market share. We are growing at three times in the market and so I do not see that necessarily having a significant impact on us this year. I think we can continue to grab market share and continue to hit our targets in relation to that. Regarding OsseoFix, we just had our meeting with the FDA; we are still in negotiation in regards to the questions that you asked. So, it is hard to give you a firm answer. I think we can provide an update once we have finalized the protocol that we believe it is not a substantial change from what companies had been asked to do before, which is somewhere around 100 patients and the follow up is still in negotiation. So, it ranges from nine months at the low end to twelve months at the high end.
Glenn Novarro – RBC Capital Market
- To read the full transcript on Seeking Alpha, click here »
